Schmid Timothy

SEC Form 4 insider
EVP, WW Chair, MedTech · JOHNSON & JOHNSON ($JNJ)
1 thesis · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d000———
1w111100%-3.5%-3.5%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$JNJSEC Form 4bearish
Sold 33,597 @ $274.74 avg · $9,230,440 · 2026-09-02

Form 4: Schmid Timothy sold JNJ

Schmid Timothy (EVP, WW Chair, MedTech at JOHNSON & JOHNSON) reported an open-market sale of 33,597 shares of JNJ at an average $274.74, roughly $9,230,440, in a Form 4 filed 2026-09-04.

At post $275.23Now $256.03-7.0% since postedas of Oct 2, 4:30 PM ET
1d—
3d—
1w-3.5%
1m—
3m—
6m—
1y—
View filing on SEC.gov →

End of results.